US Biotech companies missing R&D mark

According to Med Page Today, US biotech companies aren't getting as much out of their R&D dollars as European biotech companies. From 1993-2003, European biotech companies developed more "First-in-class"drugs than American biotech after spending for research and development was adjusted. In addition, Europe has pulled ahead, although by very little, of the research dollars spent per number of new products introduced. Read the full article here.

Share this article with your social network, just click below to share now!

Share |